|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||247.72 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Semustine is a drug used in chemotherapy. It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.
- Woolley PV, Nauta R, Smith FP, Lindblad AS, Petrelli N, Herrera L, et al. (Gastrointestinal Tumor Study Group) (April 1992). "Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group". Journal of Clinical Oncology. 10 (4): 549–57. doi:10.1200/jco.19126.96.36.1999. PMID 1548520.
- "Known and Probable Human Carcinogens". American Cancer Society.